BioClinica expands its app network; Abzena buys a contract drugmaker;

> BioClinica has recruited Medelinked to its network of clinical trial apps, adding the company's electronic patient health record technology to its platform. More

> U.K. service provider Abzena is acquiring the contract drug developer PacificGMP for $7.7 million. News

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.